Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7176
CALL
SPS Commerce
SPSC
$2.79B
| $920K | ﹤0.01% |
5,000
-900
| -15% | -$169K |
|
|
FLX
7177
BingEx Ltd
FLX
$145M
| $919K | ﹤0.01% |
+113,507
| New | +$1.23M |
|
7178
CALL
FTAI Infrastructure
FIP
$476M
| $919K | ﹤0.01% |
126,600
-2,300
| -2% | -$19.7K |
|
|
CIM
7179
PUT
Chimera Investment
CIM
$982M
| $919K | ﹤0.01% |
65,612
-203,381
| -76% | -$3.05M |
|
|
TPLE
7180
DELISTED
Timothy Plan US Large/Mid Cap Core Enhanced ETF
TPLE
| $918K | ﹤0.01% |
+35,916
| New | +$952K |
|
7181
PUT
FTI Consulting
FCN
$4.18B
| $917K | ﹤0.01% |
4,800
+400
| +9% | +$82.5K |
|
7182
PUT
Liberty Media Series C
FWONK
$25.6B
| $917K | ﹤0.01% |
9,900
-100
| -1% | -$8.49K |
|
7183
PUT
Credicorp
BAP
$29.3B
| $917K | ﹤0.01% |
5,000
+4,800
| +2,400% | +$898K |
|
7184
Horizon Bancorp
HBNC
$1.04B
| $914K | ﹤0.01% |
56,763
-62,013
| -52% | -$1.04M |
|
7185
PUT
Legend Biotech
LEGN
$4.25B
| $914K | ﹤0.01% |
28,100
+7,800
| +38% | +$323K |
|
7186
Sight Sciences
SGHT
$453M
| $914K | ﹤0.01% |
251,148
+136,448
| +119% | +$621K |
|
7187
Mercantile Bank Corp
MBWM
$1.05B
| $914K | ﹤0.01% |
20,541
+11,990
| +140% | +$557K |
|
7188
CALL
Arrowhead Research
ARWR
$12.4B
| $914K | ﹤0.01% |
48,600
+11,300
| +30% | +$233K |
|
|
CGTL
7189
Creative Global Technology Holdings
CGTL
$8.37M
| $914K | ﹤0.01% |
+7,622
| New | +$709K |
|
7190
iShares iBonds Oct 2031 Term TIPS ETF
IBIH
$70.6M
| $913K | ﹤0.01% |
+36,365
| New | +$932K |
|
7191
Angi Inc
ANGI
$188M
| $913K | ﹤0.01% |
55,019
+26,138
| +91% | +$557K |
|
7192
Upbound Group
UPBD
$1.12B
| $913K | ﹤0.01% |
31,295
-167,394
| -84% | -$5.2M |
|
|
BCIL
7193
Bancreek International Large Cap ETF
BCIL
$93.8M
| $913K | ﹤0.01% |
+36,168
| New | +$949K |
|
7194
NeoGenomics
NEO
$2.04B
| $913K | ﹤0.01% |
55,381
+36,155
| +188% | +$561K |
|
7195
MGP Ingredients
MGPI
$375M
| $912K | ﹤0.01% |
23,172
-38,713
| -63% | -$2.11M |
|
|
UTRN
7196
DELISTED
Vesper US Large Cap Short-Term Reversal Strategy ETF
UTRN
| $912K | ﹤0.01% |
30,070
+1
| +0% | +$31 |
|
7197
PUT
Prospect Capital
PSEC
$1.13B
| $911K | ﹤0.01% |
211,400
+129,300
| +157% | +$620K |
|
7198
CALL
YieldMax COIN Option Income Strategy ETF
CONY
$324M
| $910K | ﹤0.01% |
6,980
-1,600
| -19% | -$241K |
|
7199
Enanta Pharmaceuticals
ENTA
$387M
| $910K | ﹤0.01% |
158,258
-514,622
| -76% | -$4.93M |
|
7200
PUT
Teradata
TDC
$2.65B
| $910K | ﹤0.01% |
29,200
-30,700
| -51% | -$961K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.